The future is hereâ€"targeted therapies are coming of age in biliary tract cancers.
Daniel Neureiter, Matthias OckerNo abstract text is available yet for this article.
Full text links
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.